Patents/Inventors

Leslie S. Johnson

Rockville, MDUS25 patents

17 Patents

US126007792026
Lag-3-binding Molecules and Methods of Use Thereof
MACROGENICS, Inc.
0 cites
US125345312026
Pd-1-binding Molecules and Methods of Use Thereof
Macrogenics, Inc.
0 cites
US121730512024
Bispecific Molecules Comprising an HIV-1 Envelope Targeting Arm
The University Of North Carolina At Chapel Hill
0 cites
US120495012024
Cd3-binding Molecules Capable of Binding to Human and Non-human CD3
Macrogenics, In
0 cites
US120245692024
Her2/neu-specific Antibodies and Methods of Using Same
Macrogenics, Inc.
0 cites
US119421492024
Bispecific Binding Molecules That Are Capable of Binding CD137 and Tumor Antigens, and Uses Thereof
MACROGENICS, Inc.
0 cites
US118847442024
Compound Targeting IL-23A and B-cell Activating Factor (BAFF) and Uses Thereof
Macrogenics, Inc.
0 cites
US118589912024
Lag-3-binding Molecules and Methods of Use Thereof
Macrogenics, Inc.
0 cites
US118405712023
Methods of Using Bispecific Molecules Having Immunoreactivity with PD-1 and CTLA-4
MACROGENICS, Inc.
0 cites
US118208182023
Multi-chain Polypeptide-containing Tri-specific Binding Molecules
MACROGENICS, Inc.
0 cites
US117952262023
Bispecific Cd16-binding Molecules and Their Use in the Treatment of Disease
Macrogenics, Inc.
0 cites
US116976842023
Tri-specific Binding Molecules That Specifically Bind to Multiple Cancer Antigens
MACROGENICS, Inc.
0 cites
US116857812023
Variant Cd3-binding Domains and Their Use in Combination Therapies for the Treatment of Disease
0 cites
US116800962023
Compound Targeting IL-23A and Tnf-alpha and Uses Thereof
MACROGENICS, Inc.
0 cites
US116393862023
Bi-specific Monovalent Diabodies That Are Capable of Binding CD19 and CD3, and Uses Thereof
Macrogenics, Inc.
0 cites
US116239592023
Pd-1-binding Molecules and Methods of Use Thereof
MACROGENICS, Inc.
0 cites
US115914002023
B7-H3 Directed Antibody Drug Conjugates
Macrogenics, Inc.
0 cites